Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXC Technology
DXC
|
+$254M |
| 2 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$158M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$155M |
| 4 |
Intercontinental Exchange
ICE
|
+$116M |
| 5 |
Estee Lauder
EL
|
+$99.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
YHOO
Yahoo Inc
YHOO
|
+$450M |
| 2 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$184M |
| 3 |
PVTB
PrivateBancorp Inc
PVTB
|
+$130M |
| 4 |
Hewlett Packard
HPE
|
+$119M |
| 5 |
GE Aerospace
GE
|
+$98M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.23% |
| 2 | Technology | 13.9% |
| 3 | Healthcare | 12.86% |
| 4 | Industrials | 10.75% |
| 5 | Consumer Discretionary | 9.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
ImmunityBio
IBRX
$7.49B
| $2.31M | ﹤0.01% |
304,062
+122,906
| +68% | +$531K |
|
|
ZYNE
3077
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $2.31M | ﹤0.01% |
135,876
+109,770
| +420% | +$2.18M |
|
3078
Aqua Metals
AQMS
$8.82M
| $2.3M | ﹤0.01% |
915
+184
| +25% | +$521K |
|
|
SODA
3079
DELISTED
SodaStream International Ltd
SODA
| $2.29M | ﹤0.01% |
42,825
-5,753
| -12% | -$305K |
|
3080
Natural Health Trends
NHTC
$15.8M
| $2.29M | ﹤0.01% |
82,131
-1,976
| -2% | -$56.4K |
|
3081
Anavex Life Sciences
AVXL
$273M
| $2.28M | ﹤0.01% |
429,073
+59,069
| +16% | +$341K |
|
3082
Veracyte
VCYT
$3.58B
| $2.28M | ﹤0.01% |
274,001
+78,574
| +40% | +$641K |
|
|
DLA
3083
DELISTED
Delta Apparel Inc.
DLA
| $2.27M | ﹤0.01% |
102,373
+4,561
| +5% | +$88.7K |
|
|
PZN
3084
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $2.27M | ﹤0.01% |
223,334
+34,160
| +18% | +$326K |
|
|
NVDQ
3085
DELISTED
Novadaq Technologies Inc.
NVDQ
| $2.26M | ﹤0.01% |
193,177
+8,366
| +5% | +$66.2K |
|
3086
Radiant Logistics
RLGT
$393M
| $2.26M | ﹤0.01% |
420,435
+36,280
| +9% | +$209K |
|
|
TIS
3087
DELISTED
Orchids Paper Products, Inc.
TIS
| $2.26M | ﹤0.01% |
174,601
+66,977
| +62% | +$1.14M |
|
3088
Vanguard Health Care ETF
VHT
$18.1B
| $2.26M | ﹤0.01% |
15,324
+7,894
| +106% | +$1.12M |
|
|
NVTR
3089
DELISTED
Nuvectra Corporation Common Stock
NVTR
| $2.25M | ﹤0.01% |
169,659
+2,811
| +2% | +$26.7K |
|
3090
iShares MSCI South Korea ETF
EWY
$23.3B
| $2.24M | ﹤0.01% |
33,095
+5,540
| +20% | +$360K |
|
3091
Bristow Group
VTOL
$1.35B
| $2.24M | ﹤0.01% |
118,559
+6,253
| +6% | +$133K |
|
|
PCMI
3092
DELISTED
PCM, Inc
PCMI
| $2.24M | ﹤0.01% |
119,510
+92,978
| +350% | +$2.04M |
|
3093
Iovance Biotherapeutics
IOVA
$1.93B
| $2.22M | ﹤0.01% |
302,500
-402,010
| -57% | -$2.56M |
|
3094
Rush Enterprises Class B
RUSHB
$6.1B
| $2.22M | ﹤0.01% |
137,068
-6,664
| -5% | -$99.5K |
|
|
CPRX
3095
DELISTED
Catalyst Pharmaceutical
CPRX
| $2.21M | ﹤0.01% |
802,566
+691,238
| +621% | +$1.44M |
|
3096
Liquidity Services
LQDT
$1.23B
| $2.2M | ﹤0.01% |
347,062
+15,912
| +5% | +$111K |
|
|
PWOD
3097
DELISTED
Penns Woods Bancorp
PWOD
| $2.2M | ﹤0.01% |
79,995
+3,981
| +5% | +$108K |
|
|
LUMO
3098
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $2.19M | ﹤0.01% |
33,193
+1,281
| +4% | +$159K |
|
|
HOME
3099
DELISTED
At Home Group Inc.
HOME
| $2.19M | ﹤0.01% |
94,209
-4,598
| -5% | -$87.1K |
|
3100
Eastern Company
EML
$149M
| $2.19M | ﹤0.01% |
72,839
+50,708
| +229% | +$1.43M |
|
Similar funds
Northern Trust's Q2 2017 Portfolio in Review
As of Q2 2017, Northern Trust held 4,391 positions worth $358B, up 3.1% from $347B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Northern Trust's Q2 2017 filing shows 142 new, 2,528 increased, 1,287 reduced and 114 closed positions. Its largest new stake was DXC Technology: 3,833,711 shares worth $254M. The largest sale was Yahoo Inc, an estimated $450M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
- Northern Trust's largest Q2 2017 buy was DXC Technology: 3,833,711 shares worth $254M.
- Northern Trust added most to Vanguard FTSE All-World ex-US ETF in Q2 2017, an estimated $158M increase.
- Northern Trust's biggest Q2 2017 reduction was Hewlett Packard, cutting an estimated $119M.
- Northern Trust fully exited Yahoo Inc in Q2 2017, selling an estimated $450M.
- Northern Trust's ten largest holdings make up 14% of its $358B portfolio in Q2 2017.
- Northern Trust opened 142 new positions and closed 114 in Q2 2017.
- Northern Trust's portfolio value rose 3.1% quarter-over-quarter to $358B.
Based on Northern Trust's 13F filing for Q2 2017, filed 11 Aug 2017.